CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.

Kajsa Björkman,Harri Mustonen,Tuomas Kaprio,Henna Kekki,Kim Pettersson,Caj Haglund,Camilla Böckelman

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine（2021）

引用 19|浏览1

暂无评分

摘要

CA125 represents a significant and independent prognostic factor in CRC patients, superior to CEA. Furthermore, CA242 served as a better prognostic marker than both CEA and CA19-9. We recommend including both CA125 and CA242 in prognostic clinical trials among CRC patients.

查看译文

关键词

Colon cancer,ELISA,cancer prognostics,rectum cancer,serum samples

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要